Turkish Journal of Veterinary & Animal Sciences
Volume 30

Number 2

Article 19

1-1-2006

In Vitro Effects of Prostaglandin F_{2a} and Metamizol on the
Motility of Diluted Bull Semen
İZZET KARAHAN
GAFFARİ TÜRK
SEYFETTİN GÜR

Follow this and additional works at: https://journals.tubitak.gov.tr/veterinary
Part of the Animal Sciences Commons, and the Veterinary Medicine Commons

Recommended Citation
KARAHAN, İZZET; TÜRK, GAFFARİ; and GÜR, SEYFETTİN (2006) "In Vitro Effects of Prostaglandin F_{2a}
and Metamizol on the Motility of Diluted Bull Semen," Turkish Journal of Veterinary & Animal Sciences:
Vol. 30: No. 2, Article 19. Available at: https://journals.tubitak.gov.tr/veterinary/vol30/iss2/19

This Article is brought to you for free and open access by TÜBİTAK Academic Journals. It has been accepted for
inclusion in Turkish Journal of Veterinary & Animal Sciences by an authorized editor of TÜBİTAK Academic
Journals. For more information, please contact academic.publications@tubitak.gov.tr.

Turk J Vet Anim Sci
30 (2006) 271-278
© TÜB‹TAK

Research Article

In Vitro Effects of Prostaglandin F2α and Metamizol
on the Motility of Diluted Bull Semen

‹zzet KARAHAN1,*, Gaffari TÜRK2, Seyfettin GÜR2
1Department

of Pharmacology and Toxicology, Faculty of Veterinary Medicine, F›rat University, 23119 Elaz›¤ – TURKEY
2Department

of Reproduction and Artificial Insemination, Faculty of Veterinary Medicine,
F›rat University, 23119 Elaz›¤ - TURKEY

Received: 27.09.2005

Abstract: The purpose of the present study was to investigate in vitro effects of prostaglandin F2 alpha (PGF2α) and metamizol on
the motility of diluted bull semen during short-term storage at 4 ºC. In this study, 3 healthy adult Brown-Swiss bulls, each 3 years
old, were used. Semen samples were collected with an artificial vagina. Samples were taken from each bull twice a week over the
course of 3 weeks (6 samples per bull). One millilitre of semen was removed from each sample for the determination of semen
volume, mass activity, initial motility, sperm concentration, and abnormal sperm rate. The remainder of the semen samples of each
bull were diluted to a concentration of 1:10 (semen:extender) with isotonic sodium citrate + egg yolk solution. The diluted semen
samples were then divided into 12 sterile tubes of equal volume (0.5 ml). Different amounts of PGF2α [0 (PGF2α-free), 125, 250,
500, 1000, and 1500 µg] were added to 6 of these samples at 37 ºC. Similarly, different amounts of metamizol [0 (metamizolfree), 125, 250, 500, 1000, and 1500 µg] were added to the other 6 samples at 37 ºC. After the supplementation of PGF2α or
metamizol, all semen samples were stored at 4 ºC. The sperm motility of the samples was examined at 0, 1, 2, 4, 24, 48, 72, 96,
120, 144, 168, 192, and 216 h.
No significant differences in spermatological characteristics were determined between the bulls. Sperm supplementation with 125
µg and 250 µg PGF2α caused a statistically significant increase (P < 0.05) in the motility of diluted semen stored at 4 ºC after 24 h
versus diluted PGF2α-free semen. However, the supplementation with 500 µg and 1000 µg PGF2α caused significant motility
decreases after 4 h, while 1500 µg PGF2α also caused a decrease after 2 h compared to diluted PGF2α-free semen (P < 0.05). On
the other hand, metamizol supplementation of 125 µg and 250 µg significantly decreased the motility of diluted semen stored at 4
ºC after 48 hand 24 h, respectively, while 500 µg, 1000 µg, and 1500 µg of metamizol reduced motility after 4 h (P < 0.05) in
comparison to the diluted metamizol-free semen.
In conclusion, the addition of small amounts of PGF2α to diluted bull semen samples may help to maintain sperm motility during
short-term storage at 4 ºC.
Key Words: Bull, semen, PGF2α, metamizol, sperm motility

Suland›r›lm›fl Bo¤a Spermalar›n›n Motilitesi Üzerine
Prostaglandin F2α ve Metamizol’un ‹n Vitro Etkileri
Özet: Bu çal›flma, 4 ºC’da k›sa süreli saklanan suland›r›lm›fl bo¤a spermas›n›n motilitesi üzerine prostaglandin F2 alfa (PGF2α) ve
metamizolun in vitro etkilerini araflt›rmak amac›yla yap›ld›. Araflt›rmada, 3 yafl›nda, sa¤l›kl› 3 adet ‹sviçre Esmeri bo¤a kullan›ld›. Her
bir bo¤adan 3 hafta boyunca haftada iki kez olmak üzere 6 sperma örne¤i al›nd›. Her sperma örne¤inin 1 ml’si sperma miktar›, kitle
hareketi, bafllang›ç motilitesi, spermatozoon yo¤unlu¤u ve anormal spermatozoon oran›’n›n belirlenmesi için ayr›ld›. Her bo¤an›n
sperma örneklerinin geri kalan› 1:10 oran›nda (sperma:suland›r›c›) izotonik sodyum sitrat+yumurta sar›s› suland›r›c›s›yla suland›r›ld›.
Daha sonra suland›r›lm›fl sperma örnekleri eflit hacimde (0,5 ml) 12 steril tüpe konuldu. Bu örneklerin 6 tanesine PGF2α’n›n farkl›
miktarlar› (0, 125, 250, 500, 1000 and 1500 µg), benzer flekilde metamizol de ayn› miktarlarda di¤er 6 örne¤e 37 ºC’de ilave
edildi. PGF2α ve metamizol ilavesinden sonra sperma örneklerinin tümü 4 ºC’de sakland›. Bu örneklerde spermatozoon motilitesi 0,
1, 2, 4, 24, 48, 72, 96, 120, 144, 168, 192 ve 216. saatlerde belirlendi.
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Spermatolojik özellikler yönünden bo¤alar aras›nda bafllang›çta bir farkl›l›k olmad›¤› tespit edildi. Suland›r›lm›fl ve 4 ºC’de saklanan
sperma örneklerine 125 ve 250 µg PGF2α’n›n ilave edilmesi, PGF2α bulunmayan suland›r›lm›fl sperma örneklerine göre 24. saatten
sonra spermatozoon motilitesinde istatiksel olarak anlaml› (P < 0,05) bir art›fl oluflturdu. Bununla birlikte, PGF2α bulunmayan
suland›r›lm›fl sperma örneklerine göre, 500 ve 1000 µg PGF2α ilave edilmesi 4. saatten sonra, 1500 µg PGF2α ilave edilmesi ise 2.
saatten sonra spermatozoon motilitesinde anlaml› (P < 0,05) azalmalara neden oldu. Di¤er yandan, metamizol bulunmayan
suland›r›lm›fl sperma örnekleriyle karfl›laflt›r›ld›¤›nda 500 ve 1000 µg metamizol ilave edilmesi s›ras›yla 48 ve 24. saatten sonra;
metamizol’un 500, 1000 ve 1500 µg’l›k miktarlar› ise 4. saatten sonra 4 ºC’de saklanan sperma örneklerinin motilitesinde anlaml›
(P < 0,05) azalmalara neden oldu.
Sonuç olarak, suland›r›lm›fl bo¤a sperma örneklerine PGF2α’n›n düflük miktarlarda ilave edilmesinin 4 ºC’de k›sa süreli saklanmas›
esnas›nda motilitenin daha uzun süre korunmas›na yard›mc› olabilece¤i kanaatine var›ld›.
Anahtar Sözcükler: Bo¤a, sperma, PGF2α, metamizol, spermatozoon motilitesi

Introduction
Prostaglandins (PGs), which consist of 20-carbon
unsaturated fatty acids, have been found in many
mammalian tissues. PGs have a wide variety of actions,
including PGF2α, which has an important role in female
and male reproductive systems (1,2). In females, PGF2α is
formed in the granulose cells of the preovulatory follicle
in response to gonadotropins, is synthesised in the
oviduct, and contracts uterine muscle in vivo and in vitro.
The role of PGF2α in the male reproductive system,
especially in semen, is still conjectural (3,4); however,
seminal plasma is the major source of PGs (5), which are
synthesised in the seminal vesicles and secreted into
seminal plasma (6) and the prostate, whereas the testes
synthesise only small amounts (7).
The presence of high concentrations of PGF in human
seminal fluid (6,8) or the addition of high amounts of
PGF2α to the semen of humans (9) and bulls (10) is
associated with poor sperm motility. It was found that
the supplementation of semen with PGF2α increases the
rate of sperm motility in humans (11) and boars (12),
whereas some researchers reported that human semen
PGF2α (13,14) or the addition of PGF2α to diluted boar
semen (15) does not affect sperm motility. It has been
documented that while intramuscular injection of PGF2α
does not affect sperm motility in dogs (16) and horses
(17), this application decreases sperm motility in rams
(18). On the other hand, PGs cause suppression of
spermatogenesis, either by acting directly on the
seminiferous tubules or through interference with the
secretion of testosterone (19).
Metamizol has analgesic, antipyretic, and antiinflammatory effects. It is used mainly for the relief of
minor pain, particularly of musculoskeletal origin (20).
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Some studies indicate that drugs interfering with PG
metabolism, such as non-steroidal anti-inflammatory
substances, may affect male reproductive functions
(21,22). Metamizol and other anti-inflammatory
substances, such as acetylsalicylic acid and indomethacin,
are potent inhibitors of cyclooxygenase, which mediates
prostaglandin biosynthesis. Inhibition of cyclooxygenase
prevents biosynthesis of PGs (23), and may affect sperm
motility (21,24). It has been reported that the
administration of metamizol, indomethacin, and
acetylsalicylic acid affects sperm motility of several
species (18,24,25).
As mentioned above, the data regarding the in vivo or
in vitro effect of PGF2α on sperm motility are
contradictory, and there are no data about the effect of
metamizol on the motility of bull semen, in vivo or in
vitro. Therefore, the present study was conducted to
investigate in vitro effects of PGF2α and metamizol on the
motility of diluted bull semen during short-term storage.

Materials and Methods
Chemicals
PGF2α (Etiproston, Prostavet-C, 5 mg / 2 ml) was
supplied by Virbac (Carros, France) and metamizol
(Metamizol sodium, Novalgin, 1 g / 2 ml) was obtained
from Aventis (‹stanbul, Turkey). All other chemicals were
purchased from Sigma (St Louis, MO, USA) and Merck
(Darmstadt, Germany).

Animals
Three healthy adult Brown-Swiss bulls, each 3 years
old, were used in the study. The bulls, were raised at the
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Centre of Education, Research, and Application at the
Faculty of Veterinary Medicine, F›rat University, and were
kept under the natural climate conditions in Elaz›¤
province, Turkey (lat 38º40'N). The bulls were fed
concentrated meal supplemented with lucerne hay and
fresh drinking water was provided ad libitum.

Semen samples collection and determination of
spermatological characteristics
Semen was collected with an artificial vagina by using
a teaser cow in November. Samples were taken from each
bull twice a week over the course of 3 weeks (6 samples
per bull). One millilitre of semen was removed from each
sample for the determination of spermatological
characteristics. Semen volume was determined by direct
reading of the graduations markings of the collection
tubes (0.5 to 15 ml). For determination of mass activity,
a non-cover, slipped drop of fresh non-diluted semen was
placed on a warm slide (37 ºC) and placed under a light
microscope with a heated stage at 100 x magnification.
The condenser diaphragm of the microscope was lowered
in order to increase the contrast. The following
descriptors were used for mass activity: (5) rapid dark
swirls; (4) slower dark swirls and eddies; (3) slightly
slower swirls; (2) no swirls, but prominent individual cell
motion; (1) little individual cell motion; and (0) no
individual cell motion (26). Sperm concentration was
determined with a hemocytometer. Semen samples were
decimally diluted with isotonic sodium citrate solution at
37 °C (3%, w/v dissolved in distilled water) to a
concentration of 1:10 for the determination of initial
motility. A slide was placed on a light microscope with a
heated stage warmed to 37 ºC, and then a small droplet
of diluted semen was placed on the slide and % motility
was evaluated visually at a magnification of 400 x.
Motility estimations were performed from 5 different
fields in each sample. The mean of the 5 estimates was
used as the final motility score. The abnormal sperm rate
was determined from slides prepared with Indian ink. A
total of 300 sperm cells were counted on each slide under
a light microscope at 400 x magnification (27).

Samples dilution and sperm motility assay
The remainder of the semen samples of each bull
were diluted to a concentration of 1:10 (semen:extender)
with isotonic sodium citrate solution (3%, w/v dissolved

in distilled water) + egg yolk (at the rate of 20% in the
extender) extender at 37 ºC. The diluted semen samples
then containing 100 x 106 sperm/ml were then divided
into 12 sterile tubes of equal volume (0.5 ml). PGF2α at
different amounts [0 (PGF2α-free), 125, 250, 500,
1000, and 1500 µg)] was added to 6 of these tubes at
37 ºC. Additionally, different amounts of metamizol [0
(metamizol-free), 125, 250, 500, 1000, and 1500 µg)]
were added to the other 6 tubes at 37 ºC. After the
supplementation with PGF2α or metamizol, all the tubes
and non-diluted fresh semen were stored at 4 ºC. All
samples were examined at 0, 1, 2, 4, 24, 48, 72, 96,
120, 144, 168, 192, and 216 h for sperm motility. The
measurement of the motility of the diluted semen was
performed in the same manner as the initial measurement
of the non-diluted sperm motility.

Statistical analysis
The data are presented as mean ± SEM (standard
error of means). All initial spermatological characteristics
and motility of semen supplemented both with PGF2α and
metamizol were analysed with General Linear Model
(GLM) procedures. The statistical models included the
effect of bull, semen, PGF2α, metamizol, and time. Mean
differences were determined with post-hoc LSD test. A
value of P < 0.05 was considered statistically significant.
All data were analysed with SPSS (Version 10.0).

Results
Spermatological characteristics of the bulls are given
in Table 1. No significant differences in spermatological
characteristics were determined between bulls and
different ejaculates of the same bull (P > 0.05).
The motility rates (%) of non-diluted fresh semen,
diluted PGF2α-free semen, and diluted semen containing
the different amounts of PGF2α are presented in Table 2.
The available (50% or more) motilities continued up to 2
h for non-diluted fresh semen and 72 h for diluted semen
with free PGF2α. Diluted semen with 125 and 250 µg
PGF2α added maintained available motilities up to 96 h.
While the available motility of diluted semen with
500 µg PGF2α added was maintained for 24 h, diluted
semen with 1000 and 1500 µg PGF2α added maintained
motility for 4 h. In other words, the supplementation
with 125 and 250 µg PGF2α caused a statistically
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Table 1. Spermatological characteristics of the bulls.

Spermatological Characteristics
Bull
Numbers

Semen
Volume
(ml)

Mass
Activity
(0-5)

Initial
Motility
(%)

Sperm
Concentration
(….x106/ml)

Abnormal Sperm Rate (%)
Head

Tail

Total

1

3.50 ± 0.88

3.87 ± 0.23

85.25 ± 1.49

912.50 ± 86.21

3.93 ± 0.47

3.69 ± 0.54

7.62 ± 0.24

2

3.62 ± 0.42

3.75 ± 1.44

81.75 ± 1.03

988.14 ± 63.44

2.68 ± 0.85

4.37 ± 0.43

7.05 ± 0.14

3

3.32 ± 0.53

3.36 ± 0.24

85.48 ± 0.95

879.34 ± 52.92

2.63 ± 0.32

4.30 ± 0.48

6.93 ± 0.24

Means

3.48 ± 0.09

3.66 ± 0.15

84.16 ± 1.21

926.66 ± 32.20

3.08 ± 0.43

4.12 ± 0.22

7.20 ± 0.21

- Data are presented as mean ± SEM.
- No significant differences in spermatological characteristics were determined between bulls and different ejaculates of the same bull (P > 0.05).

significant increase (P < 0.05) in the motility of diluted
semen stored at 4 ºC for 24 h versus diluted PGF2α-free
semen. On the other hand, the supplementation with 500
and 1000 µg PGF2α caused significant motility decreases
after 4 h, while 1500 µg PGF2α also caused a decrease
after 2 h compared to diluted PGF2α-free semen (P <
0.05).
The motility rates (%) of non-diluted fresh bull
semen, diluted metamizol-free semen, and diluted semen
containing different amounts of metamizol stored at 4 ºC
for 168 h are given in Table 3. The available motility of
non-diluted fresh semen was maintained for up to 4 h.
Although both diluted metamizol-free semen and diluted
semen with 125 µg metamizol added maintained available
motility by decreasing during 72 h, the available motilities
of diluted semen with 250 and 500 µg metamizol
continued for 48 h. However, diluted semen with 1000
and 1500 µg metamizol maintained available motility for
24 h. Metamizol supplementation with 125 and 250 µg
significantly decreased the motility of diluted semen after
48 and 24 h, respectively, while the motility of diluted
sperm with 500, 1000, and 1500 µg of metamizol added
decreased after 4 h (P < 0.05) in comparison to diluted
metamizol-free semen.

Discussion
In the present study, the effects of PGF2α and
metamizol on the sperm motility of bulls were
investigated because of conflicting reports about the
effects of PGs and possible use of PGs in the regulation
of male fertility. The male and female reproductive tract
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is involved in PGF2α synthesis and high concentrations of
PGF2α are existent in seminal fluid (5) and cervical mucus
(2). It has been documented that intramuscular injection
of PGF2α does not affect sperm motility in dogs (16) or
horses (17); however, this application of PGF2α decreases
the sperm motility of rams (18). In humans, the
concentration of 19-OH- PGE is higher and 19-OH- PGF
is lower in ejaculates with normal sperm motility than in
those with abnormal motility (8). Gottlieb et al. (14)
suggested that PGs are important regulators of sperm
motility and that this effect may be mediated via effects
on the ATP content in spermatozoa. One important
function of seminal PGs is to stimulate the kinetic activity
and motility of spermatozoa at the time of ejaculation (3).
It was found that the supplementation of semen with
PGF2α increases the rate of motility in humans (11) and
boars (12). In the present study, it was observed that the
supplementation with 125 and 250 µg PGF2α caused
increases in the motility of diluted semen stored at 4 ºC
after 24 h versus diluted PGF2α-free semen. The increase
seen in sperm motility after the addition of low amounts
of PGF2α to the diluted bull semen can be explained by the
direct effect of PGs on spermatozoa possibly acting on
the contractile elements of the sperm, as in other tissues
(3,4). The presence of high concentrations of PGF in
seminal fluid is associated with poor sperm motility. (6).
Post-thaw progressive motility is depressed by the
addition of the salt of PGF2α (28). Didolkar and
Roychowdhury (29) have alleged that PGF1α and PGF2α
reduced motility of sperm in vitro in humans, whereas
some researchers reported that human semen PGF2α
(13,14) or the addition of PGF2α to diluted boar semen

71.33Aa ± 1.85

74.00Aa ± 1.25

77.50Aa ± 1.26

79.83Aa ± 1.11

80.53Aa ± 1.36

59.83ACab ± 2.48

65.50ABab ± 1.89

73.16BCa ± 1.50

76.16Bab ± 1.26

75.50Bab ± 1.32

72.33BCab ± 1.37

58.16Ab ± 1.40

2

4

52.16ADb ± 1.86

59.66CDb ± 2.48

70.33BCab ± 1.77

73.83Bab ± 1.54

73.66Bab ± 1.41

71.88BCab ± 1.65

42.16Ac ± 1.03

-The values with different lowercases (a, b, c, d and e) within the same line are statistically different (P < 0.05).

-The values with different uppercases (A, B, C and D) within the same column are statistically different (P < 0.05).

67.83Aa ± 2.00

72.50Aab ± 1.11

76.66Aa ± 1.20

79.33Aa ± 1.06

77.33Aab ± 1.23

74.66Aab ± 0.98

77.33Aa ± 0.92

82.16Aa ± 0.74

75.66Aa ± 1.14

1

0

- Data are presented as mean ± SEM.

(with 1500 µg PGF2α)

Diluted Semen

(with 1000 µg PGF2α)

Diluted Semen

(with 500 µg PGF2α)

Diluted Semen

(with 250 µg PGF2α)

Diluted Semen

(with 125 µg PGF2α)

Diluted Semen

(PGF2α-free)

Diluted Semen

(Non-Diluted)

Fresh Semen

Groups

7.50Ac ± 0.70

34.66Dc ± 1.90

57.33Cbc ± 1.43

70.66Bab ± 1.54

71.33Bab ± 1.57

62.00BCbc ± 1.80

2.66Ad ± 0.46

24

0

14.00Cd ± 1.42

46.33Acd ± 1.19

69.83Bab ± 1.67

70.00Bab ± 2.06

56.00Ac ± 2.85

0

48

-

1.50De ± 0.42

34.33Cd ± 1.62

64.83Bb ± 2.55

66.66Bb ± 2.27

50.66Ac ± 2.79

-

72

-

0

5.33Ce ± 1.99

50.50Bc ± 3.69

51.83Bc ± 4.00

17.33Ad ± 3.69

-

96

Time (hour)

-

-

0

15.33Bd ± 3.06

16.66Bd ± 4.37

5.16Ae ± 1.80

-

120

-

-

-

9.66Bd ± 3.06

10.00Bde ± 3.39

1.66Ae ± 0.69

-

144

-

-

-

7.00Ade ± 2.92

8.00Ade ± 3.33

0

-

168

-

-

192

-

-

-

3.66Ae ± 1.55

3.83Ae ± 1.62

Table 2. The motility rates (%) of non-diluted fresh semen, diluted PGF2α-free semen, and diluted semen containing different amounts of PGF2α over 216 h.

-

-

-

0

0

-

-

216
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74.50Aa ± 0.96

75.33Aa ± 1.04

76.33Aa ± 0.98

76.00Aa ± 0.90

75.83Aa ± 0.68

67.83Aa ± 0.61

68.83Aab ± 0.61

69.66Aab ± 0.63

71.83Aab ± 0.81

72.33Aab ± 0.88

75.16Aab ± 0.77

63.50Abc ± 0.90

2

63.33ABab ± 0.90

65.16ABab ± 0.94

65.16ABabc ± 1.00

67.50ABab ± 1.11

68.66Babc ± 1.09

73.50Bab ± 0.83

55.16Ac ± 1.13

4

-The values with different lowercases (a, b, c, d, e and f) within the same line are statistically different (P < 0.05).

-The values with different uppercases (A, B, C and D) within the same column are statistically different (P < 0.05).

73.33Aa ± 0.93

74.33Aa ± 1.00

74.83Aa ± 0.97

75.50Aa ± 0.96

74.83Aa ± 0.94

77.33Aab ± 0.78

74.66Aab ± 0.79

79.16Aa ± 0.68

78.50Aa ± 0.64

1

0

- Data are presented as mean ± SEM.

(with 1500 µg Metamizol)

Diluted Semen

(with 1000 µg Metamizol)

Diluted Semen

(with 500 µg Metamizol)

Diluted Semen

(with 250 µg Metamizol)

Diluted Semen

(with 125 µg Metamizol)

Diluted Semen

(Metamizol-free)

Diluted Semen

(Non-Diluted)

Fresh Semen

Groups

53.33Cb ± 0.93

55.66Cbc ± 1.11

57.83Cbc ± 1.06

59.66BCbd ± 0.71

61.50BCbcd ± 0.68

71.50Bab ± 0.68

6.00Ad ± 0.55

24

36.00Cc ± 1.66

45.83BCc ± 1.22

52.66Bcd ± 0.82

54.16Bcd ± 0.93

57.83ABcd ± 0.61

69.00Aab ± 0.50

0

48

19.66Dd ± 1.28

31.66CDd ± 1.38

42.66BCd ± 0.92

47.00Bd ± 0.85

50.66Bd ± 0.39

64.66Ab ± 0.62

-

72

0

6.50De ± 0.68

17.33CDe ± 1.14

19.00Ce ± 1.41

33.33Be ± 0.79

47.50Ac ± 0.74

-

96

Time (hour)

-

0

0

0

14.00Bf ± 1.40

30.00Ad ± 1.00

-

120

-

-

-

-

0

10.33e ± 0.53

-

144

Table 3. The motility rates (%) of non-diluted fresh semen, diluted metamizol-free semen, and diluted semen containing different amounts of metamizol over 168 h.

-

-

-

-

0

-

168
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(15) does not affect sperm motility. On the other hand,
Cohen et al. (9) determined that when PGF2α is added in
greater than physiological concentrations, it can also
reduce sperm motility in vitro in humans, and also
suggested that PGF2α stimulates the production of cyclic
GMP, a substance that has been shown to markedly
reduce sperm motility. Fayed (10) has also reported that
in vitro supplementation with high levels of PGF2α (300,
600 and 1200 µg/ml) to diluted bull epididymal
spermatozoa suppressed motility and even induced sperm
membrane damage and permeability. It is clearly seen
that sperm motility is related to the concentration of
PGF2α. In this study, sperm supplementation with 500,
1000, and 1500 µg PGF2α caused significant decreases in
motility. The decreases in sperm motility induced by high
amounts of PGF2α noted in the present study are
consistent with the findings of other investigators. These
decreases may be explained by the stimulation of
production of cyclic GMP by PGF2α.
Metamizol is a highly potent analgesic and antipyretic
used especially in the treatment of pain and hyperthermia
(20). Metamizol and other anti-inflammatory substances
are potent inhibitors of cyclooxygenase, which mediates
prostaglandin biosynthesis (23). The motility of
spermatozoa is dependent on the presence of certain
amounts of PGs, which have a protective function on
sperm motility, possibly acting as cytoprotective agents
(1). Therefore, inhibition of this enzyme prevents
biosynthesis of PGs (4,22,23), and a rapid fall in sperm
motility consequently occurs (17,21). Tany›ld›z› and
Bozkurt (25) observed that intramuscular administration
of metamizol and oral intake of acetylsalicylic acid twice
daily for 4 days caused an increase in motility of ram
semen. Conte et al. (24) observed that when seminal PG
levels are high, PG inhibition by indomethacin will cause a
significant improvement in sperm count and motility, but
not normal-low seminal PG levels. Acetylsalicylic acid
reduces sperm count and percentage of motility, and
causes alterations in the morphological characteristics of
spermatozoa by affecting the epididymal milieu in postpubertal rats (30). On the other hand, it has been

reported that intramuscular administration of
indomethacin (3, 6, and 9 mg/kg) has no effect on
motility or other spermatological features in rams (18).
In the present study, sperm supplementation with
different amounts of metamizol decreased the motility of
diluted semen stored at 4 °C in comparison to diluted
metamizol-free semen. The findings of this study are
compatible with the in vivo results of some researchers
that have investigated metamizol and other substances,
while they are not compatible with others. This situation
may be dependent on in vitro use and the amounts of
metamizol, and the use of different animal species.
Metamizol also has a significant inhibiting effect on
the activity of the glucose 6-phosphate dehydrogenase
enzyme, which catalyses the first step of the pentose
phosphate metabolic pathway, both in vivo and in vitro.
(31). The pentose phosphate metabolic pathway is a
unique source of NADPH and NAD+, of which the addition
and/or presence as an energy source could prevent the
time-dependent decrease of motility (6). Consequently,
inactivation of glucose 6-phosphate dehydrogenase by
metamizol may cause a reduction in sperm motility. In the
present study, a time-dependent decrease was observed
in the motility of bull semen after supplementation with
different amounts of metamizol, and this may be
explained by the inhibition of cyclooxygenase and/or
glucose 6-phosphate dehydrogenase.
In conclusion, the addition of small amounts of PGF2α
to diluted bull semen that contained 100 x 106 sperm/ml,
but not metamizol or large amounts of PGF2α, helped
maintain motility during short-term storage at 4 °C.
Therefore, sperm could be supplemented with small
amounts of PGF2α, which may be effective for improving
sperm motility in bulls.
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